Developer docs
API playgroundTry for free, no card

Search company profiles

Evidenced

Full company profile

uuid00066hb

Namestring
Evidenced
Legal namestring
Evidenced Capital Management LP
Websiteurl
evidenced.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Evidenced is a Washington, DC-based venture capital firm that invests in early-stage healthcare technology companies positioned to benefit from U.S. regulatory tailwinds. The firm is structured as Evidenced Capital Management LP, a subsidiary of Ventura Capital, and was co-founded by Sean Glass and Bryan Sivak. It is led by a two-person GP team whose prior experience spans the U.S. Department of Health and Human Services, Kaiser Permanente Ventures, Centene Corporation, and prior operating roles scaling healthcare and enterprise software companies (Advantia Health to roughly $100M in revenue; Higher One, taken public in 2010; InQuira, sold to Oracle).

The firm's product is a single investment fund that deploys capital across roughly ten named healthcare portfolio companies spanning primary and behavioral care (Accompany Health, Journey Clinical), benefit access (Fabric Health), VR therapeutics (Floreo), community health workers (IMPaCT Care), home safety (Jukebox Health), advance care planning (Koda Health), parental leave insurance (Parento), AI-enabled community pharmacy services (Truentity Health), and consumer prescription infrastructure (Photon Health). The firm provides portfolio companies with regulatory insight, operational support, and introductions to its strategic Limited Partner network.

Revenue is generated through standard venture fund economics: management fees on committed capital and carried interest on portfolio exits. Distribution to investors runs through a direct relationship channel targeting nine named strategic LPs, including major health insurers (CVS Aetna, United Healthcare, Centene, Humana), integrated providers (Kaiser Permanente, Cleveland Clinic), retail pharmacy (Walgreens), and federal health agencies (CMS, HHS). Go-to-market is relationship-driven rather than productized, leveraging the founding team's network for both deal sourcing and LP fundraising.

Short descriptiontext

Evidenced is a Washington, DC-based early-stage venture capital firm investing in U.S. healthcare technology companies that benefit from regulatory tailwinds, serving qualified institutional and strategic Limited Partners through a curated portfolio of healthcare startups.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital fund, healthcare investing, early-stage investments, seed stage capital, regulatory-driven investment
Industry2 codes
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Other Investment Pools and Funds5259
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Healthcare Investment
Social media profiles1 record
Revenue model1 record
1Fund Management
TypeLicensing Royalties
Description

Evidenced operates as a venture capital fund generating returns through management fees and carried interest from portfolio company exits. The fund capitalizes on government-driven opportunities in healthcare technology, selecting globally-sourced companies that benefit from U.S. regulatory tailwinds.

evidenced.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Evidenced operates a venture capital fund that invests in early-stage healthcare technology companies positioned to benefit from U.S. regulatory tailwinds. The firm sources globally-sourced portfolio companies and provides them with capital deployment, strategic regulatory insight, and operational expertise to drive accelerated growth. Investment participation spans direct funding rounds (e.g., leading Truentity Health's $3.5M Series A and participating in Photon Health's $16M Series A).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Evidenced is a venture capital firm operating as a single unified investment fund that provides capital deployment and strategic expertise to healthcare technology companies. The firm leverages its government insights and operational expertise to identify and support early-stage companies benefiting from U.S. regulatory tailwinds. The portfolio includes investments across multiple healthcare verticals including primary care, digital health, virtual reality therapeutics, community health, and insurance services.

Product and service2 records
1Evidenced VC Fund
CategoryVenture Capital Fund
2Investment Strategy Services
CategoryInvestment Advisory Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers9 records
TypeBroad incumbent
TypeDirect peer
Description

Healthcare-focused venture firm led by Amir Dan Rubin that invests in early-stage companies transforming care delivery; the lead investor in Photon Health's $16M Series A that Evidenced also participated in, making it a directly comparable sector-focused VC competing for the same deals.

TypeDirect peer
Description

Early-stage venture firm exclusively focused on digital health and healthcare technology, also participated in Photon Health's $16M Series A; directly comparable in stage, sector focus, and check size to Evidenced.

TypeDirect peer
Description

Dedicated early-stage digital health venture fund investing across care delivery, payer, and provider enablement; comparable in stage, healthcare-only mandate, and thesis of backing category-defining companies.

TypeDirect peer
Description

Healthcare-focused VC investing in companies serving Medicaid, Medicare, and dual-eligible populations — a population-centric thesis that closely parallels Evidenced's regulatory-tailwind approach to government-payor-driven care models.

TypeBroad incumbent
Description

Large multi-stage venture firm with a dedicated healthcare and resilience practice that competes for the same digital health and value-based care deals, but with materially larger fund size and broader sector mandate.

TypeBroad incumbent
Description

Specialist venture firm investing in healthcare services and financial technology, often at early-stage, with a thematic approach comparable to Evidenced's regulatory-driven healthcare thesis but with larger fund vehicles and a longer track record.

TypeBroad incumbent
Description

Strategic corporate venture arm of Kaiser Permanente investing in healthcare technology; led by Bryan Sivak before Evidenced, and a strategic LP in Evidenced's fund — making it both a competitor and a partner.

TypeBroad incumbent
Description

Long-established multi-stage venture firm with a dedicated healthcare franchise investing across payers, providers, and digital health; broader mandate and larger funds but overlapping in target stage and sectors.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evidenced

Venture Capital / Healthcare Investmentevidenced.com

Evidenced is a Washington, DC-based early-stage venture capital firm investing in U.S. healthcare technology companies that benefit from regulatory tailwinds, serving qualified institutional and strategic Limited Partners through a curated portfolio of healthcare startups.

What Evidenced does

Evidenced is a Washington, DC-based venture capital firm that invests in early-stage healthcare technology companies positioned to benefit from U.S. regulatory tailwinds. The firm is structured as Evidenced Capital Management LP, a subsidiary of Ventura Capital, and was co-founded by Sean Glass and Bryan Sivak. It is led by a two-person GP team whose prior experience spans the U.S. Department of Health and Human Services, Kaiser Permanente Ventures, Centene Corporation, and prior operating roles scaling healthcare and enterprise software companies (Advantia Health to roughly $100M in revenue; Higher One, taken public in 2010; InQuira, sold to Oracle).

The firm's product is a single investment fund that deploys capital across roughly ten named healthcare portfolio companies spanning primary and behavioral care (Accompany Health, Journey Clinical), benefit access (Fabric Health), VR therapeutics (Floreo), community health workers (IMPaCT Care), home safety (Jukebox Health), advance care planning (Koda Health), parental leave insurance (Parento), AI-enabled community pharmacy services (Truentity Health), and consumer prescription infrastructure (Photon Health). The firm provides portfolio companies with regulatory insight, operational support, and introductions to its strategic Limited Partner network.

Revenue is generated through standard venture fund economics: management fees on committed capital and carried interest on portfolio exits. Distribution to investors runs through a direct relationship channel targeting nine named strategic LPs, including major health insurers (CVS Aetna, United Healthcare, Centene, Humana), integrated providers (Kaiser Permanente, Cleveland Clinic), retail pharmacy (Walgreens), and federal health agencies (CMS, HHS). Go-to-market is relationship-driven rather than productized, leveraging the founding team's network for both deal sourcing and LP fundraising.

Evidenced firmographics

Firmographics
Name
Evidenced
Legal name
Evidenced Capital Management LP
Website
https://evidenced.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Evidenced is a Washington, DC-based early-stage venture capital firm investing in U.S. healthcare technology companies that benefit from regulatory tailwinds, serving qualified institutional and strategic Limited Partners through a curated portfolio of healthcare startups.
Ownership category
akta.pro rank

Evidenced industry classification

Industry
Product category
Venture Capital / Healthcare Investment
NAICS
Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAAAB
Early-Stage Venture Capital (Series A/B)

Keywords

  • Venture capital fund
  • Healthcare investing
  • Early-stage investments
  • Seed stage capital
  • Regulatory-driven investment

Where Evidenced is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Markets served

Evidenced business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management: Evidenced operates as a venture capital fund generating returns through management fees and carried interest from portfolio company exits. The fund capitalizes on government-driven opportunities in healthcare technology, selecting globally-sourced companies that benefit from U.S. regulatory tailwinds.

Distribution channels1 record

Marketing channels2 records

Evidenced product offering

Product offering

Core offering

Evidenced operates a venture capital fund that invests in early-stage healthcare technology companies positioned to benefit from U.S. regulatory tailwinds. The firm sources globally-sourced portfolio companies and provides them with capital deployment, strategic regulatory insight, and operational expertise to drive accelerated growth. Investment participation spans direct funding rounds (e.g., leading Truentity Health's $3.5M Series A and participating in Photon Health's $16M Series A).

Product overview

Evidenced is a venture capital firm operating as a single unified investment fund that provides capital deployment and strategic expertise to healthcare technology companies. The firm leverages its government insights and operational expertise to identify and support early-stage companies benefiting from U.S. regulatory tailwinds. The portfolio includes investments across multiple healthcare verticals including primary care, digital health, virtual reality therapeutics, community health, and insurance services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Evidenced VC Fund
  • Investment Strategy Services

Companies that use Evidenced

Customer profile

Segments1 record

Ideal customer profiles2 records

Evidenced technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Evidenced partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves1 record

Expansion highlights5 records

Evidenced competitors and assessment

Company assessment

Broad incumbents

  • CVS Health Ventures:
  • General Catalyst (Health & Resilience practice): Large multi-stage venture firm with a dedicated healthcare and resilience practice that competes for the same digital health and value-based care deals, but with materially larger fund size and broader sector mandate.
  • Oak HC/FT: Specialist venture firm investing in healthcare services and financial technology, often at early-stage, with a thematic approach comparable to Evidenced's regulatory-driven healthcare thesis but with larger fund vehicles and a longer track record.
  • Kaiser Permanente Ventures: Strategic corporate venture arm of Kaiser Permanente investing in healthcare technology; led by Bryan Sivak before Evidenced, and a strategic LP in Evidenced's fund — making it both a competitor and a partner.
  • Bessemer Venture Partners (Healthcare): Long-established multi-stage venture firm with a dedicated healthcare franchise investing across payers, providers, and digital health; broader mandate and larger funds but overlapping in target stage and sectors.

Direct peers

  • Healthier Capital: Healthcare-focused venture firm led by Amir Dan Rubin that invests in early-stage companies transforming care delivery; the lead investor in Photon Health's $16M Series A that Evidenced also participated in, making it a directly comparable sector-focused VC competing for the same deals.
  • Flare Capital Partners: Early-stage venture firm exclusively focused on digital health and healthcare technology, also participated in Photon Health's $16M Series A; directly comparable in stage, sector focus, and check size to Evidenced.
  • Define Ventures: Dedicated early-stage digital health venture fund investing across care delivery, payer, and provider enablement; comparable in stage, healthcare-only mandate, and thesis of backing category-defining companies.
  • Town Hall Ventures: Healthcare-focused VC investing in companies serving Medicaid, Medicare, and dual-eligible populations — a population-centric thesis that closely parallels Evidenced's regulatory-tailwind approach to government-payor-driven care models.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Evidenced social profiles

Digital presence

Evidenced financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evidenced leadership team

Management profile

Number of profiles

Profiles2 records

Evidenced funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evidenced M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evidenced

What does Evidenced do?

Evidenced operates a venture capital fund that invests in early-stage healthcare technology companies positioned to benefit from U.S. regulatory tailwinds. The firm sources globally-sourced portfolio companies and provides them with capital deployment, strategic regulatory insight, and operational expertise to drive accelerated growth. Investment participation spans direct funding rounds (e.g., leading Truentity Health's $3.5M Series A and participating in Photon Health's $16M Series A).

Is Evidenced a public or private company?

Evidenced is a private company. It is classified as corporate owned and is currently operating.

When was Evidenced founded?

Evidenced was founded in -1. It employs 1 to 10 people.

Where is Evidenced based?

Evidenced is headquartered in Washington, United States, in the North America region.

How does Evidenced make money?

One revenue line is on record: fund Management.

Who are Evidenced's main competitors?

Broad incumbents on record are CVS Health Ventures, General Catalyst (Health & Resilience practice), Oak HC/FT, Kaiser Permanente Ventures and Bessemer Venture Partners (Healthcare). Direct peers are Healthier Capital, Flare Capital Partners, Define Ventures and Town Hall Ventures.

Does Evidenced have an API?

No public API is recorded for Evidenced.

What industry is Evidenced in?

Evidenced's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HomepageEvidenced Closes $24M Fund I to Back Health Tech Startups Riding Regulatory TailwindsEvidenced, a Washington D.C.-based venture firm, has closed Fund I at $24 million with backing from the Rockefeller Foundation, RockCreek Group, and Colibri Equity Ventures. The firm was co-founded in 2022 by Sean Glass and Bryan Sivak and invests in health tech startups positioned to benefit from regulatory tailwinds such as the CMS ACCESS model. Portfolio companies include 12 startups spanning behavioral health, aging-in-place, obesity care, and neurodiverse therapeutics.VC News DailyIlant Health Nabs $15M Series A FinancingIlant Health raised $15 million in Series A funding led by Cornucopian Capital, bringing total funding to over $22 million. The obesity and cardiometabolic health company provides value-based treatment through bariatric surgery, medication, and behavioral therapy.Longevity.TechnologyIlant’s AI-powered obesity care model raises $15mIlant Health raised $15 million in Series A financing led by Cornucopian Capital, bringing total funding to over $22 million. The New York-based company combines medical treatment, behavioral therapy, nutrition, and surgery with AI to personalize obesity care. Early program members achieved an average 15% weight loss.TechStartupsIlant Health raises $15M to use AI for obesity care as employers rethink costly GLP-1 coverageIlant Health raised $15 million in Series A funding led by Cornucopian Capital, bringing total funding to over $22 million. The New York-based startup uses AI to help employers manage obesity care costs, claiming members achieve an average 15% weight loss. The company is working with Eli Lilly and Novo Nordisk.Venture Capital Access OnlineIlant Health Raises $15M to Replace Fragmented Obesity Care With AI-supported, Precision CareIlant Health raised $15 million in Series A funding led by Cornucopian Capital, bringing total funding to over $22 million. The company reports members achieve 15% weight loss on average, versus 5.8% in real-world settings, and is working with Lilly and Novo Nordisk.MedCity NewsIlant Health Raises $15M to Advance Obesity CareIlant Health, an obesity care company, raised $15 million in Series A funding led by Cornucopian Capital. The company reports its members achieve a 15% average weight loss, compared to 5.8% in routine clinical practice. It plans to expand precision medicine capabilities as new treatments enter the market.VentureburnIlant Health Raises $15 Million to Expand Value-Based Obesity CareIlant Health raised $15 million in Series A funding led by Cornucopian Capital, bringing total funding to over $22 million. The company reports an average 15% weight loss among participants and plans to expand employer and health plan partnerships. It aims to grow value-based obesity care with personalized treatment and transparent pricing.FinSMEsIlant Health Raises $15M in Series A FundingIlant Health, a New York City-based AI-supported precision obesity and cardiometabolic care platform, raised $15M in Series A funding led by Cornucopian Capital. The company, which has raised $22M total, will use the funds to expand value-based care infrastructure and accelerate commercial deployment with large employer groups and managed care plans.HospitalogyPhoton Just Killed the “E” in E-PrescribingPhoton Health raised $16M in Series A funding led by Healthier Capital, with participation from Notation, Flare Capital Partners, and Evidenced, to build a consumer-facing interface layer on top of e-prescribing that helps integrated delivery networks capture ambulatory pharmacy consumer relationships. The article argues that health systems are leaving $50M to $250M annually on the table by treating ambulatory pharmacy as a fulfillment cost center rather than a high-frequency consumer engagement engine tied to lifetime value. The piece further positions the funding within a broader healthcare transformation where AI prescribing will re-architect the prescription workflow, and health systems that fail to act risk losing consumer lifetime value to tech companies like Amazon Pharmacy.AlleyWatchThe AlleyWatch Startup Daily Funding Report: 4/30/2026Photon Health, a digital prescription platform enabling patients to compare pharmacies on price and availability, has secured $16M in Series A funding led by Healthier Capital, with participation from Notation, Flare Capital, and Evidenced. The round brings the company's total equity funding to $32.4M since its founding in 2021 by Otto Sipe, Michael Rado, and Sam Kotlove.